Podophyllum Peltatum Herb

Podophyllum peltatum contains podophyllotoxin, which inhibits microtubule assembly during cell division. This antimitotic action prevents cells from completing mitosis, effectively stopping cellular replication. The herb's active compounds, including alpha-peltatin and beta-peltatin, bind to tubulin proteins, disrupting spindle fiber formation. This mechanism underlies both its traditional use for wart removal and its development into anticancer pharmaceuticals like etoposide. Evidence Level: C (preclinical and mechanistic studies support this action).

Podophyllum peltatum has significant drug interaction potential, particularly with other cytotoxic or antimitotic medications. Concurrent use with chemotherapy drugs may increase bone marrow suppression and toxicity. Topical podophyllin preparations can enhance absorption of other topical agents, increasing systemic toxicity risk. The herb should not be combined with immunosuppressants or other purgatives. Due to severe toxicity risks, any use requires medical supervision. Evidence Level: C (based on pharmacological properties and case reports).

Podophyllum peltatum should only be used under medical supervision due to severe toxicity risks. For topical wart treatment, healthcare providers apply 0.5% podophyllin solution directly to lesions, typically in weekly intervals. Internal use is contraindicated due to potentially fatal systemic toxicity. Self-medication is strongly discouraged. The crude herb is not available for consumer use; only pharmaceutical preparations containing standardized podophyllotoxin derivatives are used clinically. Evidence Level: C (professional guidelines).

Podophyllum peltatum is absolutely contraindicated during pregnancy. The herb contains podophyllotoxin, a known abortifacient that can cause fetal death and spontaneous abortion. Even topical application poses significant risks as podophyllotoxin can be absorbed through the skin into systemic circulation. Pregnant women, those attempting to conceive, and nursing mothers must avoid all exposure to this herb and its preparations. Evidence Level: C (established contraindication based on pharmacological properties and historical documentation).

Podophyllum peltatum causes severe systemic toxicity when taken internally, including nausea, vomiting, diarrhea, abdominal pain, and potentially fatal outcomes. Neurological effects include peripheral neuropathy, dizziness, and confusion. Topical application may cause local irritation, ulceration, and burning sensations. Systemic absorption from topical use can lead to bone marrow suppression and organ damage. Children are particularly vulnerable to toxicity. The crude plant is dangerously poisonous and should never be consumed. Evidence Level: C (based on toxicological data and case reports).